Arrowstreet Capital Limited Partnership Raises Stock Holdings in Agilent Technologies, Inc. $A

Arrowstreet Capital Limited Partnership lifted its holdings in Agilent Technologies, Inc. (NYSE:A) by 472.5% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 221,993 shares of the medical research company’s stock after acquiring an additional 183,220 shares during the quarter. Arrowstreet Capital Limited Partnership owned 0.08% of Agilent Technologies worth $26,197,000 as of its most recent SEC filing.

Other hedge funds also recently bought and sold shares of the company. Brighton Jones LLC increased its position in Agilent Technologies by 6.1% during the fourth quarter. Brighton Jones LLC now owns 4,663 shares of the medical research company’s stock worth $626,000 after purchasing an additional 270 shares during the last quarter. Cary Street Partners Financial LLC grew its holdings in Agilent Technologies by 2.9% during the 1st quarter. Cary Street Partners Financial LLC now owns 3,688 shares of the medical research company’s stock worth $431,000 after acquiring an additional 103 shares in the last quarter. Charles Schwab Investment Management Inc. increased its holdings in shares of Agilent Technologies by 0.5% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 1,708,940 shares of the medical research company’s stock valued at $199,912,000 after acquiring an additional 8,151 shares during the last quarter. Chicago Partners Investment Group LLC purchased a new stake in Agilent Technologies in the first quarter valued at $210,000. Finally, Mitsubishi UFJ Asset Management Co. Ltd. raised its holdings in shares of Agilent Technologies by 11.6% in the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 515,035 shares of the medical research company’s stock valued at $60,249,000 after buying an additional 53,550 shares during the last quarter. Hedge funds and other institutional investors own 87.41% of the company’s stock.

Wall Street Analyst Weigh In

A has been the topic of a number of analyst reports. Robert W. Baird increased their target price on Agilent Technologies from $142.00 to $165.00 and gave the company an “outperform” rating in a report on Tuesday, November 25th. Barclays boosted their price target on shares of Agilent Technologies from $145.00 to $165.00 and gave the company an “equal weight” rating in a report on Tuesday, November 25th. Rothschild & Co Redburn began coverage on shares of Agilent Technologies in a research report on Wednesday, October 8th. They issued a “buy” rating and a $165.00 price target on the stock. Bank of America increased their target price on shares of Agilent Technologies from $150.00 to $165.00 and gave the stock a “neutral” rating in a research report on Tuesday, November 25th. Finally, Evercore ISI raised their price objective on Agilent Technologies from $128.00 to $140.00 and gave the company an “in-line” rating in a research note on Tuesday, October 7th. One research analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating and five have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $161.08.

Insider Activity

In other news, VP Rodney Gonsalves sold 3,000 shares of Agilent Technologies stock in a transaction on Wednesday, November 26th. The stock was sold at an average price of $154.99, for a total value of $464,970.00. Following the completion of the transaction, the vice president directly owned 31,846 shares in the company, valued at approximately $4,935,811.54. The trade was a 8.61% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Padraig Mcdonnell sold 12,490 shares of the stock in a transaction on Wednesday, November 12th. The stock was sold at an average price of $150.00, for a total value of $1,873,500.00. Following the completion of the sale, the chief executive officer owned 33,448 shares in the company, valued at $5,017,200. This trade represents a 27.19% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 16,401 shares of company stock valued at $2,468,962 in the last quarter. Corporate insiders own 0.26% of the company’s stock.

Agilent Technologies Stock Performance

NYSE:A opened at $145.45 on Friday. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.52 and a current ratio of 1.96. The company has a market capitalization of $41.24 billion, a PE ratio of 31.83, a P/E/G ratio of 4.22 and a beta of 1.27. The company has a 50 day simple moving average of $144.84 and a two-hundred day simple moving average of $128.01. Agilent Technologies, Inc. has a fifty-two week low of $96.43 and a fifty-two week high of $160.27.

Agilent Technologies (NYSE:A) last issued its earnings results on Monday, November 24th. The medical research company reported $1.59 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.58 by $0.01. Agilent Technologies had a net margin of 18.75% and a return on equity of 25.20%. The business had revenue of $1.86 billion for the quarter, compared to analyst estimates of $1.83 billion. During the same period in the prior year, the firm earned $1.46 earnings per share. Agilent Technologies’s revenue was up 9.4% on a year-over-year basis. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. Research analysts anticipate that Agilent Technologies, Inc. will post 5.58 earnings per share for the current year.

Agilent Technologies Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 28th. Shareholders of record on Tuesday, January 6th will be given a $0.255 dividend. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.25. This represents a $1.02 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend is Tuesday, January 6th. Agilent Technologies’s dividend payout ratio (DPR) is 22.32%.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.